AI-Powered Health Tech Boosts Women’s Health in Vietnam with TruScreen’s New Screening Initiative

3 min read | April 22, 2025 10:37 AM AEST | By Team Kalkine Media

Google News:

AI-Powered Health Tech Boosts Women’s Health in Vietnam with TruScreen’s New Screening Initiative — Image source: shutterstock

Recent News

Zip Shares Push Higher as Market Watches Key Turning Point

Could These Under-the-Radar ASX Stocks Be Worth Watching?

ASX 200 Soars as Trump Signals Surprise Iran Peace Shift

Which ASX Small Caps Are Making Early Moves Today?

Make Kalkine Media
My Trusted Source

Highlights

TruScreen Group initiates a five-year AI-enabled cervical cancer screening drive in Vietnam.

260,000 women to be screened across Ho Chi Minh City under public-private collaboration.

TruScreen Ultra offers real-time, non-invasive results with high accessibility and efficiency.

In a significant move towards enhancing women's health in Southeast Asia, Sydney-based biotech firm TruScreen Group (ASX:TRU) has kicked off a five-year cervical cancer screening program in Ho Chi Minh City, Vietnam. The initiative leverages the company’s advanced TruScreen Ultra screening device, a real-time, non-invasive cervical screening tool powered by artificial intelligence.

Public Health Collaboration Reaches Grassroots

The large-scale community-based program, announced through a collaboration with the Ho Chi Minh City Public Health Association and Gorton Health Services, is set to reach approximately 260,000 women. This initiative targets Vietnam’s most densely populated urban area and aims to improve early detection rates through convenient, tech-driven diagnostics.

As part of the partnership, the Ho Chi Minh City Public Health Association will oversee logistics including community outreach, mobilization of social workers, and coordination with local authorities. Gorton Health Services will manage the import and installation of the TruScreen Ultra devices, provide training for healthcare personnel, and collect screening data for evaluation.

Major medical institutions including Tu Du Hospital, Hung Vuong Hospital, and Ung Buou Hospital will provide technical backing, while screenings will be conducted at district health centres and private high-tech clinics.

Fulfilling National Health Priorities

This program aligns with Vietnam’s 2016 National Action Plan on Cervical Cancer Prevention, which underscores the importance of advanced screening tools to identify pre-cancerous changes and ensure timely intervention. The plan’s goal is to screen 60% of sexually active women aged 30 to 54, with emphasis on high-risk groups such as smokers and individuals with HPV or HIV.

Currently, national screening rates are around 25% of the eligible 36 million women, highlighting a significant opportunity for impact.

Cutting-Edge Device Brings Real-Time Results

The TruScreen Ultra device offers an innovative approach by delivering instant results without requiring cytology or tissue sampling. It eliminates the need for complex lab infrastructure and is designed for ease of use in community settings. Its portability and quick diagnostic capabilities make it ideal for large-scale public health programs, especially in resource-limited environments.

The device was officially added to Vietnam’s National Technical List in December 2023, enabling its integration into both public and private healthcare services. To date, over 200 devices have been installed across countries including China, Mexico, Zimbabwe, Russia, and Saudi Arabia.

With this program, TruScreen Group (ASX:TRU) strengthens its mission to improve access to life-saving screening technology and empower health systems globally.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.